MYELINEASE™ G 300
MYELINEASE™ G 300
Gabapentin Tablets I.P. 300 mg
High-Tech Support for Neuropathic Pain & Seizure Control
MYELINEASE™ G 300 of Levencare Life Sciences Pvt. Ltd. has Gabapentin 300 mg, a commonly prescribed drug that is very effective in controlling neuropathic pain and also as an adjuvant in some seizure disorders. Manufactured under strict quality standards, MYELINEASE™ G 300 demonstrates LevenCare’s commitment to offering evidence-based, patient-centered therapy.
Key Features
Gabapentin 300 mg
Neuropathic Pain Relief: Often prescribed to relieve pain related to nerve disorders like diabetic neuropathy and post-herpetic neuralgia.
Seizure Control: May be used in combination with other antiepileptic drugs to control partial onset seizures.
WHO GMP-Certified Manufacturing
We are committed to procuring our products by WHO GMP certified selected and audited high tech manufacturing units of international standards.
Trusted Formulation
High Efficacy & Purity: Every tablet ensures a correct dosage of gabapentin with the support of stringent testing and quality inspection.
LevenCare Assurance
Two Decades of Professionalism: The vast experience of our team is the foundation of our commitment to reliability, affordability, and ethical practices.
Indication
Neuropathic Pain: Perfect for long-term nerve pain control, like diabetic neuropathy or nerve pain after shingles (post-herpetic neuralgia).
Adjunctive Seizure Therapy: Aids in the control of partial seizures when used together with other antiepileptic medications.
Levencare Life Sciences Pvt. Ltd.
Founded in 2022 and incorporated with the Registrar of Companies, Mumbai, LevenCare functions on the principle of selfless care. Our objective is to produce high-quality, evidence-based pharmaceutical and nutraceutical products at affordable prices. With a specialization in Obstetrics & Gynecology, Orthopaedics, Neurology, Medicine, Nephrology, and Gastroenterology, we work towards maintaining our commitment to WHO GMP-certified manufacturing practices, where every product meets stringent global standards.
Our Vision
To avoid, maintain, and heal health diseases globally by providing research-based, higher-quality, and affordable drugs. We believe in empowering medical professionals with reliable solutions, indicating our unflinching commitment to patient well-being.
Dosage & Safety Information
Prescription Only:
MYELINEASE™ G 300 must be administered under the strict supervision of a healthcare professional.
Usual Dosage:
Determined by condition and patient profile. Always adhere to your physician’s prescribed dosage.
Potential Side Effects:
May be dizziness, drowsiness, or tiredness. In case of severe or long-lasting side effects, report them to your healthcare provider at once.
Precautions:
Tell your doctor about any current medical conditions or other medications.
Be careful when driving or using machines until you know how this drug impacts you.
Not intended during pregnancy or lactation except with a medical professional’s advice.
Storage:
Store in a cool, dry place away from direct light. Keep out of the reach of children.
Experience the LevenCare Difference
By selecting MYELINEASE™ G 300, you select a product that reflects LevenCare’s unwavering dedication to quality, ethics, and patient-centered care. Place your trust in our expertise to assist healthcare professionals and patients in the path towards better health and well-being.